brodalumab 210 MG in 1.5 ML Prefilled Syringe

RxCUI: 1872256
RxNorm name: brodalumab 210 MG in 1.5 ML Prefilled Syringe
Display name: brodalumab 210 MG in 1.5 ML Prefilled Syringe
Full name: brodalumab 210 MG in 1.5 ML Prefilled Syringe
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:49

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761032	Siliq	brodalumab	351(a)	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Siliq	BRODALUMAB	Bausch Health US LLC	1a550c33-456a-4833-814e-8591aea7c688	2026-05-28	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1872256

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
1a550c33-456a-4833-814e-8591aea7c688	brodalumab 210 MG in 1.5 ML Prefilled Syringe [PSN] · 1.5 ML brodalumab 140 MG/ML Prefilled Syringe [SCD] · brodalumab 210 MG per 1.5 ML Prefilled Syringe [SY]	3	22	These highlights do not include all the information needed to use SILIQ safely and effectively. See full prescribing information for SILIQ. SILIQ ® (brodalumab) injection, for subcutaneous use Initial U.S. Approval: 2017	20260528